Poor
Poorly Aligned
Patient Risk:
Moderate
Summary
Only a few class/mechanism claims are supported by the provided label excerpts (DESCRIPTION/CLINICAL PHARMACOLOGY). Most other claims (indications, side effects, and generic/patent assertions) are not supported by the provided excerpts, and key safety labeling sections (contraindications/warnings/dosing/ADRs) are not available for verification.
Category Scores
Accurate Statements
Prednisone is a corticosteroid.
Supported in part by DESCRIPTION: "Prednisone is a glucocorticoid."
Prednisone is a synthetic corticosteroid.
Supported in part by DESCRIPTION/CLINICAL PHARMACOLOGY: "both naturally occurring and synthetic"
Prednisone acts as an anti-inflammatory.
Supported by CLINICAL PHARMACOLOGY: "primarily used for their potent anti-inflammatory effects"
Prednisone works by decreasing inflammation.
Supported by CLINICAL PHARMACOLOGY: "potent anti-inflammatory effects"
Prednisone acts as an immunosuppressant.
Partially consistent with CLINICAL PHARMACOLOGY: "modify the body’s immune responses"
Prednisone works by reducing the activity of the immune system.
Partially consistent with CLINICAL PHARMACOLOGY: "modify the body’s immune responses"
Unsupported Statements
Prednisone does not have active patent protection that would prevent generic versions from being sold.
Not addressed in provided DESCRIPTION/CLINICAL PHARMACOLOGY excerpts.
Prednisone’s original patents have long since expired.
Not addressed in provided DESCRIPTION/CLINICAL PHARMACOLOGY excerpts.
Prednisone was first approved by the U.S. Food and Drug Administration in 1958.
Not addressed in provided DESCRIPTION/CLINICAL PHARMACOLOGY excerpts.
Because prednisone is no longer under patent protection, pharmaceutical companies are free to manufacture and sell generic versions of the drug.
Not addressed in provided DESCRIPTION/CLINICAL PHARMACOLOGY excerpts.
Prednisone is readily available in generic form at significantly lower costs than brand-name patented drugs.
Market/cost statement not addressed in provided label excerpts.
Numerous pharmaceutical manufacturers produce generic versions of prednisone.
Not addressed in provided label excerpts.
Prednisone helps alleviate symptoms associated with allergies.
No INDICATIONS content provided to support this claim.
Prednisone helps alleviate symptoms associated with asthma.
No INDICATIONS content provided to support this claim.
Prednisone helps alleviate symptoms associated with autoimmune diseases.
No INDICATIONS content provided to support this claim.
Prednisone helps alleviate symptoms associated with certain types of cancer.
No INDICATIONS content provided to support this claim.
Common side effects of prednisone can include increased appetite.
No ADVERSE REACTIONS/WARNINGS content provided to support this claim.
Common side effects of prednisone can include weight gain.
No ADVERSE REACTIONS/WARNINGS content provided to support this claim.
Common side effects of prednisone can include mood changes.
No ADVERSE REACTIONS/WARNINGS content provided to support this claim.
Common side effects of prednisone can include difficulty sleeping.
No ADVERSE REACTIONS/WARNINGS content provided to support this claim.
Common side effects of prednisone can include fluid retention.
No ADVERSE REACTIONS/WARNINGS content provided to support this claim.
More serious side effects of prednisone with long-term use can involve a weakened immune system.
No WARNINGS/PRECAUTIONS/ADVERSE REACTIONS content provided to support this claim.
More serious side effects of prednisone with long-term use can include bone thinning (osteoporosis).
No WARNINGS/PRECAUTIONS/ADVERSE REACTIONS content provided to support this claim.
More serious side effects of prednisone with long-term use can include high blood sugar.
No WARNINGS/PRECAUTIONS/ADVERSE REACTIONS content provided to support this claim.
More serious side effects of prednisone with long-term use can include cataracts.
No WARNINGS/PRECAUTIONS/ADVERSE REACTIONS content provided to support this claim.
More serious side effects of prednisone with long-term use can include increased risk of infections.
No WARNINGS/PRECAUTIONS/ADVERSE REACTIONS content provided to support this claim.
The specific side effects and their severity can depend on the dosage and duration of treatment.
No WARNINGS/PRECAUTIONS/ADVERSE REACTIONS content provided to support this claim.
Prednisone is prescribed to treat inflammatory and autoimmune conditions.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat severe allergies.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat asthma.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat inflammatory bowel diseases like Crohn’s disease.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat inflammatory bowel diseases like ulcerative colitis.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat rheumatoid arthritis.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat lupus.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat multiple sclerosis.
No INDICATIONS content provided to support this claim.
Prednisone is prescribed to treat certain skin conditions.
No INDICATIONS content provided to support this claim.
Prednisone is used in chemotherapy regimens.
No INDICATIONS content provided to support this claim.
Prednisone is used to prevent organ transplant rejection.
No INDICATIONS content provided to support this claim.
Contradictions
Important Omissions
Key safety labeling sections required for evaluation (CONTRAINDICATIONS, WARNINGS/BOXED WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, DOSAGE AND ADMINISTRATION, and Use in Specific Populations such as Pregnancy/Pediatrics) were not provided, so multiple safety-related claims cannot be verified against the FDA-approved label.
Importance:
High
Safety Assessment
Potential Patient Risk:
Moderate
Many claims about adverse effects and specific indications are not supported by the provided label excerpts; additionally, critical safety sections (contraindications/warnings/ADRs/dosing) were not available for verification, preventing confirmation that the information aligns with approved labeling.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Poorly Aligned
Primary Issue
Most extracted claims (indications, adverse effects, and patent/generic/cost assertions) are not supported by the provided FDA label excerpts (DESCRIPTION/CLINICAL PHARMACOLOGY only), and safety-critical label sections required for verification are missing.
Suggested Improvement
Limit statements to those supported by the provided excerpts (e.g., glucocorticoid class and anti-inflammatory/immune-response modification) or provide full label sections for INDICATIONS, ADVERSE REACTIONS, WARNINGS, CONTRAINDICATIONS, and DOSAGE/ADMINISTRATION before evaluating and asserting specific clinical uses and side effects.